# EDGAR Filing Document

**Accession Number:** 0001595725
**File Stem:** 0001172661-25-003729
**Filing Date:** 2025-8
**Character Count:** 47304
**Document Hash:** e056cc4f8a6b74e0fe9492627e84a0d9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001172661-25-003729.hdr.sgml**: 20250822

**ACCESSION NUMBER**: 0001172661-25-003729

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250822

**EFFECTIVENESS DATE**: 20250822

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Rock Springs Capital Management LP
- **CENTRAL INDEX KEY:** 0001595725

**ORGANIZATION NAME:**
- **EIN:** 800944416
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-16048
- **FILM NUMBER:** 251244181

**BUSINESS ADDRESS:**
- **STREET 1:** 650 SOUTH EXETER STREET
- **STREET 2:** SUITE 1070
- **CITY:** BALTIMORE
- **STATE:** MD
- **ZIP:** 21202
- **BUSINESS PHONE:** 4102200129

**MAIL ADDRESS:**
- **STREET 1:** 650 SOUTH EXETER STREET
- **STREET 2:** SUITE 1070
- **CITY:** BALTIMORE
- **STATE:** MD
- **ZIP:** 21202

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001595725

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Rock Springs Capital Management LP

**Address:** 650 SOUTH EXETER STREET, BALTIMORE, MD 21202

**Telephone number:** 410-220-0129

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-16048

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                     | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                                    | VOTE CATEGORY                |     SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| Leap Therapeutics, Inc.            | 52187K200 | 07/02/2024     | Advisory vote on executive compensation paid to named executive officers ("Say-on-Pay Proposal").                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES | 911937           |                0 | FOR         |                         911937           | FOR                         |  |
| Accolade, Inc.                     | 00437E102 | 08/06/2024     | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement in accordance with SEC rules.                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |      3.02e+06    |                0 | FOR         |                              3.02e+06    | FOR                         |  |
| Immunovant, Inc.                   | 45258J102 | 08/12/2024     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |      1.16769e+06 |                0 | FOR         |                              1.16769e+06 | FOR                         |  |
| Rhythm Pharmaceuticals, Inc.       | 76243J105 | 09/18/2024     | Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company.                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |      1.23549e+06 |                0 | FOR         |                              1.23549e+06 | FOR                         |  |
| Freshpet, Inc.                     | 358039105 | 10/01/2024     | Non-binding advisory vote to approve the compensation of the Company's named executive officers                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |   1245           |                0 | FOR         |                           1245           | FOR                         |  |
| Azenta, Inc.                       | 114340102 | 01/30/2025     | To approve by a non-binding advisory vote the compensation of the Company's named executive officers.                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES | 506000           |                0 | FOR         |                         506000           | FOR                         |  |
| Nevro Corp.                        | 64157F103 | 04/02/2025     | To approve, on a non-binding, advisory basis, certain compensation that will or may be paid or become payable to Nevro's named executive officers that is based on or otherwise relates to the Merger; and                                                          | SECTION 14A SAY-ON-PAY VOTES |      1.8481e+06  |                0 | AGAINST     |                              1.8481e+06  | AGAINST                     |  |
| Boston Scientific Corporation      | 101137107 | 05/01/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES | 420500           |                0 | FOR         |                         420500           | FOR                         |  |
| Inspire Medical Systems, Inc.      | 457730109 | 05/01/2025     | Approval, on an advisory (non-binding) basis, of the compensation of the Company's named executive officers.                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES | 106600           |                0 | FOR         |                         106600           | FOR                         |  |
| Intuitive Surgical, Inc.           | 46120E602 | 05/01/2025     | To approve, by advisory vote, the compensation of the Company's Named Executive Officers.                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES | 206250           |                0 | FOR         |                         206250           | FOR                         |  |
| Biohaven Ltd.                      | G1110E107 | 05/05/2025     | A non-binding advisory vote on the compensation of the Company's named executive officers.                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |  62452           |                0 | FOR         |                          62452           | FOR                         |  |
| Eli Lilly and Company              | 532457108 | 05/05/2025     | Approval, on an advisory basis, of the compensation paid to the company's named executive officers.                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES | 129500           |                0 | FOR         |                         129500           | FOR                         |  |
| Danaher Corporation                | 235851102 | 05/06/2025     | To approve on an advisory basis the Company's named executive officer compensation.                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |  57400           |                0 | FOR         |                          57400           | FOR                         |  |
| West Pharmaceutical Services, Inc. | 955306105 | 05/06/2025     | Advisory vote to approve named executive officer compensation;                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |   3707           |                0 | FOR         |                           3707           | FOR                         |  |
| Alnylam Pharmaceuticals, Inc.      | 02043Q107 | 05/08/2025     | To approve, in a non-binding advisory vote, the compensation of Alnylam's named executive officers.                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES | 211750           |                0 | FOR         |                         211750           | FOR                         |  |
| DexCom, Inc.                       | 252131107 | 05/08/2025     | To provide a non-binding advisory vote on the compensation of our named executive officers for the fiscal year ended December 31, 2024.                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES | 353500           |                0 | FOR         |                         353500           | FOR                         |  |
| Edwards Lifesciences Corporation   | 28176E108 | 05/08/2025     | Advisory Vote to Approve Named Executive Officer Compensation                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES | 432785           |                0 | FOR         |                         432785           | FOR                         |  |
| Mereo BioPharma Group Plc          | 589492107 | 05/13/2025     | That the compensation of the Company's named executive officers be approved, on an advisory (non-binding) basis.                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |      6.68425e+06 |                0 | FOR         |                              6.68425e+06 | FOR                         |  |
| Mereo BioPharma Group Plc          | 589492107 | 05/13/2025     | That the frequency of future advisory votes on the compensation of the Company's named executive officers be approved, on an advisory (non-binding) basis.                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |      6.68425e+06 |                0 | THREE YEARS |                              6.68425e+06 | FOR                         |  |
| Prothena Corporation plc           | G72800108 | 05/13/2025     | To approve, in a non-binding advisory vote, the compensation of the executive officers named in the Company's Proxy Statement for the Annual General Meeting.                                                                                                       | SECTION 14A SAY-ON-PAY VOTES | 508524           |                0 | FOR         |                         508524           | FOR                         |  |
| SpringWorks Therapeutics, Inc.     | 85205L107 | 05/14/2025     | Non-binding advisory vote on executive compensation                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES | 183117           |                0 | FOR         |                         183117           | FOR                         |  |
| Vera Therapeutics, Inc.            | 92337R101 | 05/14/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES | 407164           |                0 | FOR         |                         407164           | FOR                         |  |
| Vera Therapeutics, Inc.            | 92337R101 | 05/14/2025     | To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers.                                                                                                             | SECTION 14A SAY-ON-PAY VOTES | 407164           |                0 | ONE YEAR    |                         407164           | FOR                         |  |
| Insmed Incorporated                | 457669307 | 05/15/2025     | An advisory vote on the 2024 compensation of our named executive officers.                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES | 517000           |                0 | FOR         |                         517000           | FOR                         |  |
| Travere Therapeutics, Inc.         | 89422G107 | 05/15/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |      3.04794e+06 |                0 | FOR         |                              3.04794e+06 | FOR                         |  |
| Ultragenyx Pharmaceutical Inc.     | 90400D108 | 05/15/2025     | Advisory (non-binding) vote to approve the compensation of our named executive officers.                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |      1.37109e+06 |                0 | FOR         |                              1.37109e+06 | FOR                         |  |
| MacroGenics, Inc.                  | 556099109 | 05/21/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy materials.                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |      1.05415e+06 |                0 | FOR         |                              1.05415e+06 | FOR                         |  |
| Merus N.V.                         | N5749R100 | 05/21/2025     | Approval, on an advisory (non-binding) basis, of the compensation of Merus N.V.'s named executive officers.                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES | 800994           |           233409 | FOR         |                         800994           | FOR                         |  |
| Neurocrine Biosciences, Inc.       | 64125C109 | 05/21/2025     | Advisory vote on the compensation paid to the Company's named executive officers;                                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES | 340850           |                0 | FOR         |                         340850           | FOR                         |  |
| Pulmonx Corporation                | 745848101 | 05/22/2025     | To conduct a non-binding advisory vote to approve our executive compensation.                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES | 501353           |                0 | AGAINST     |                         501353           | AGAINST                     |  |
| SCHOLAR ROCK HOLDING CORPORATION   | 80706P103 | 05/22/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES | 545933           |                0 | FOR         |                         545933           | FOR                         |  |
| Tenet Healthcare Corporation       | 88033G407 | 05/22/2025     | To approve, on an advisory basis, the Company's executive compensation.                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES | 130000           |                0 | FOR         |                         130000           | FOR                         |  |
| 89bio, Inc.                        | 282559103 | 05/28/2025     | Approval of, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES | 841434           |                0 | FOR         |                         841434           | FOR                         |  |
| agilon health, inc.                | 00857U107 | 05/28/2025     | To approve, by advisory vote, the compensation paid to the Company's named executive officers.                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |      6.95e+06    |                0 | FOR         |                              6.95e+06    | FOR                         |  |
| Arcellx, Inc.                      | 03940C100 | 05/28/2025     | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement.                                                                | SECTION 14A SAY-ON-PAY VOTES |   9443           |                0 | FOR         |                           9443           | FOR                         |  |
| iRhythm Technologies, Inc.         | 450056106 | 05/28/2025     | To approve, on a non-binding advisory basis, the named executive officer compensation.                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES | 254300           |                0 | FOR         |                         254300           | FOR                         |  |
| Penumbra, Inc.                     | 70975L107 | 05/28/2025     | To approve, on an advisory basis, the compensation of Penumbra, Inc.'s named executive officers as disclosed in the proxy statement;                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES | 171000           |                0 | FOR         |                         171000           | FOR                         |  |
| Perspective Therapeutics, Inc.     | 46489V302 | 05/28/2025     | To consider and vote on a proposal to approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.                                                                                     | SECTION 14A SAY-ON-PAY VOTES | 444383           |                0 | AGAINST     |                         444383           | AGAINST                     |  |
| Acadia Healthcare Company, Inc.    | 00404A109 | 05/29/2025     | Advisory vote on the compensation of the Company's named executive officers as presented in the Proxy Statement.                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES | 681100           |                0 | FOR         |                         681100           | FOR                         |  |
| Acadia Healthcare Company, Inc.    | 00404A109 | 05/29/2025     | Advisory vote on the frequency of a non-binding advisory vote on the Compensation of the Company's named executive officers.                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES | 681100           |                0 | ONE YEAR    |                         681100           | FOR                         |  |
| Adaptimmune Therapeutics Plc       | 00653A107 | 05/29/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers for the year ended December 31, 2024.                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |      2.48347e+06 |                0 | FOR         |                              2.48347e+06 | FOR                         |  |
| Adaptimmune Therapeutics Plc       | 00653A107 | 05/29/2025     | To approve, on a non-binding, advisory basis, the preferred frequency of future shareholder advisory votes on the compensation of the Company's named executive officers.                                                                                           | SECTION 14A SAY-ON-PAY VOTES |      2.48347e+06 |                0 | ONE YEAR    |                              2.48347e+06 | FOR                         |  |
| Mirum Pharmaceuticals, Inc.        | 604749101 | 05/29/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES | 951765           |                0 | FOR         |                         951765           | FOR                         |  |
| Dyne Therapeutics, Inc.            | 26818M108 | 05/30/2025     | To vote, on an advisory basis, to approve the compensation of our named executive officers.                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES | 524499           |                0 | FOR         |                         524499           | FOR                         |  |
| Dyne Therapeutics, Inc.            | 26818M108 | 05/30/2025     | To hold an advisory vote on the frequency of future advisory votes on the compensation of our named executive officers.                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES | 524499           |                0 | ONE YEAR    |                         524499           | FOR                         |  |
| UnitedHealth Group Incorporated    | 91324P102 | 06/02/2025     | Advisory approval of the Company's executive compensation.                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES | 100500           |                0 | AGAINST     |                         100500           | AGAINST                     |  |
| Akero Therapeutics, Inc.           | 00973Y108 | 06/03/2025     | To consider and act upon a non-binding, advisory vote to approve the compensation of our named executive officers.                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES | 669147           |                0 | FOR         |                         669147           | FOR                         |  |
| Apellis Pharmaceuticals, Inc.      | 03753U106 | 06/03/2025     | To hold an advisory vote to approve the compensation paid to our named executive officers;                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |  80000           |                0 | FOR         |                          80000           | FOR                         |  |
| Apellis Pharmaceuticals, Inc.      | 03753U106 | 06/03/2025     | To hold an advisory vote on the frequency of future advisory votes on the compensation paid to our named executive officers; and                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |  80000           |                0 | ONE YEAR    |                          80000           | FOR                         |  |
| NewAmsterdam Pharma Company N.V.   | N62509109 | 06/04/2025     | Non-binding, advisory vote to approve the 2024 compensation of named executive officers.                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES | 519149           |                0 | FOR         |                         519149           | FOR                         |  |
| NewAmsterdam Pharma Company N.V.   | N62509109 | 06/04/2025     | Non-binding, advisory vote regarding frequency of future shareholders' advisory votes on the compensation of named executive officers.                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES | 519149           |                0 | ONE YEAR    |                         519149           | FOR                         |  |
| Oscar Health, Inc.                 | 687793109 | 06/04/2025     | Approval, on an advisory (non-binding) basis, of the compensation of our named executive officers.                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |      1.05e+06    |                0 | FOR         |                              1.05e+06    | FOR                         |  |
| Xenon Pharmaceuticals Inc.         | 98420N105 | 06/04/2025     | To approve, on an advisory basis, the compensation of the Corporation's named executive officers;                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES | 927950           |                0 | FOR         |                         927950           | FOR                         |  |
| Aclaris Therapeutics, Inc.         | 00461U105 | 06/05/2025     | To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement accompanying this proxy card.                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |      5.04631e+06 |                0 | AGAINST     |                              5.04631e+06 | AGAINST                     |  |
| Amicus Therapeutics, Inc.          | 03152W109 | 06/05/2025     | Approval, on an advisory basis, the Company's executive compensation.                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |      1.90936e+06 |                0 | FOR         |                              1.90936e+06 | FOR                         |  |
| Amylyx Pharmaceuticals, Inc.       | 03237H101 | 06/05/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executives officers.                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES | 481285           |                0 | AGAINST     |                         481285           | AGAINST                     |  |
| Celldex Therapeutics, Inc.         | 15117B202 | 06/05/2025     | To approve, on an advisory basis, the compensation of the Company's Named Executive Officers as disclosed in this Proxy Statement.                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES | 812653           |                0 | FOR         |                         812653           | FOR                         |  |
| Evolent Health, Inc.               | 30050B101 | 06/05/2025     | Proposal to approve the compensation of our named executive officers for 2024 on an advisory basis.                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |      2.6957e+06  |                0 | FOR         |                              2.6957e+06  | FOR                         |  |
| Pliant Therapeutics, Inc.          | 729139105 | 06/05/2025     | To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation.                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES | 346703           |                0 | AGAINST     |                         346703           | AGAINST                     |  |
| Applied Therapeutics, Inc.         | 03828A101 | 06/09/2025     | To approve (on a non-binding advisory basis) the compensation of our named executive officers as described in the accompanying materials.                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |      2.07489e+06 |                0 | FOR         |                              2.07489e+06 | FOR                         |  |
| Applied Therapeutics, Inc.         | 03828A101 | 06/09/2025     | To approve (on a non-binding advisory basis) the frequency of an advisory vote on the compensation of our named executive officers in future years.                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |      2.07489e+06 |                0 | ONE YEAR    |                              2.07489e+06 | FOR                         |  |
| Alphatec Holdings, Inc.            | 02081G201 | 06/11/2025     | To approve, on an advisory basis, the compensation of our named executive officers.                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES | 267500           |                0 | FOR         |                         267500           | FOR                         |  |
| Janux Therapeutics, Inc.           | 47103J105 | 06/11/2025     | Approval, on an advisory basis, of the compensation of our named executive officers ("Say-On-Pay"), as disclosed in the accompanying Proxy Statement.                                                                                                               | SECTION 14A SAY-ON-PAY VOTES | 204466           |                0 | FOR         |                         204466           | FOR                         |  |
| Janux Therapeutics, Inc.           | 47103J105 | 06/11/2025     | Indication, on an advisory basis, of the preferred frequency of holding future Say-On-Pay votes on the compensation of our named executive officers.                                                                                                                | SECTION 14A SAY-ON-PAY VOTES | 204466           |                0 | ONE YEAR    |                         204466           | FOR                         |  |
| Korro Bio, Inc.                    | 500946108 | 06/11/2025     | Non-Binding Advisory Vote to Approve the Compensation of our Named Executive Officers;                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |      5           |                0 | FOR         |                              5           | FOR                         |  |
| Korro Bio, Inc.                    | 500946108 | 06/11/2025     | Non-Binding Advisory Vote on the Frequency of Future Non-Binding Advisory Votes to Approve the Compensation of our Named Executive Officers                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |      5           |                0 | ONE YEAR    |                              5           | FOR                         |  |
| Cullinan Therapeutics, Inc.        | 230031106 | 06/12/2025     | Proposal to vote, on an advisory basis, to approve our named executive officer compensation.                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES | 644633           |                0 | FOR         |                         644633           | FOR                         |  |
| Cullinan Therapeutics, Inc.        | 230031106 | 06/12/2025     | Proposal to vote, on an advisory basis, on the frequency of future advisory votes on our named executive officer compensation.                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES | 644633           |                0 | ONE YEAR    |                         644633           | FOR                         |  |
| Exact Sciences Corporation         | 30063P105 | 06/12/2025     | To approve, on an advisory basis, the compensation of our named executive officers.                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES | 490500           |                0 | FOR         |                         490500           | FOR                         |  |
| Mersana Therapeutics, Inc.         | 59045L205 | 06/12/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |      3.81413e+06 |                1 | FOR         |                              3.81413e+06 | FOR                         |  |
| Neurogene, Inc.                    | 64135M105 | 06/12/2025     | To approve on an an (non-binding) basis the compensation of the Company's named executive officers.                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES | 104339           |                0 | FOR         |                         104339           | FOR                         |  |
| Summit Therapeutics Inc.           | 86627T108 | 06/12/2025     | Approval, by a non-binding advisory vote, of the compensation of our named executive officers.                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES | 570994           |                0 | AGAINST     |                         570994           | AGAINST                     |  |
| Tarsus Pharmaceuticals, Inc.       | 87650L103 | 06/12/2025     | To hold an advisory vote to approve, on a non-binding basis, named executive officer compensation.                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES | 335244           |                0 | FOR         |                         335244           | FOR                         |  |
| Tarsus Pharmaceuticals, Inc.       | 87650L103 | 06/12/2025     | To hold an advisory vote to approve, on a non-binding basis, the frequency with which future stockholder votes on the compensation of our named executive officers will be conducted of one, two or three years.                                                    | SECTION 14A SAY-ON-PAY VOTES | 335244           |                0 | ONE YEAR    |                         335244           | FOR                         |  |
| Vaxcyte, Inc.                      | 92243G108 | 06/12/2025     | Approval, on a non-binding, advisory basis, of the compensation of the Company's named executive officers.                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |  11100           |                0 | AGAINST     |                          11100           | AGAINST                     |  |
| Regeneron Pharmaceuticals, Inc.    | 75886F107 | 06/13/2025     | Proposal to approve, on an advisory basis, executive compensation.                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |   2800           |                0 | FOR         |                           2800           | FOR                         |  |
| Agios Pharmaceuticals, Inc.        | 00847X104 | 06/18/2025     | To vote, on an advisory basis, to approve the compensation paid to our named executive officers.                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES | 342180           |                0 | FOR         |                         342180           | FOR                         |  |
| Ardelyx, Inc.                      | 039697107 | 06/18/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the proxy statement accompanying this notice pursuant to the compensation disclosure rules of the Securities and Exchange Commission ("Say-on-Pay"); | SECTION 14A SAY-ON-PAY VOTES |      1.66578e+06 |                0 | FOR         |                              1.66578e+06 | FOR                         |  |
| Blueprint Medicines Corporation    | 09627Y109 | 06/18/2025     | Approval of a non-binding advisory vote on the compensation paid to our named executive officers.                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES | 865256           |                0 | FOR         |                         865256           | FOR                         |  |
| Nuvalent, Inc.                     | 670703107 | 06/18/2025     | To approve, on an advisory basis, the compensation paid to our named executive officers.                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES | 427532           |                0 | FOR         |                         427532           | FOR                         |  |
| Zai Lab Limited                    | 98887Q104 | 06/18/2025     | THAT, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement, is hereby approved.                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES | 365631           |                0 | AGAINST     |                         365631           | AGAINST                     |  |
| Madrigal Pharmaceuticals, Inc.     | 558868105 | 06/20/2025     | Advisory vote to approve executive compensation                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES | 166698           |                0 | FOR         |                         166698           | FOR                         |  |
| Madrigal Pharmaceuticals, Inc.     | 558868105 | 06/20/2025     | Advisory vote to approve the frequency of future advisory votes to approve executive compensation                                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES | 166698           |                0 | ONE YEAR    |                         166698           | FOR                         |  |
| Novavax, Inc.                      | 670002401 | 06/20/2025     | The approval, on an advisory basis, of the compensation paid of our Named Executive Officers.                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES | 400000           |                0 | FOR         |                         400000           | FOR                         |  |
| Structure Therapeutics Inc.        | 86366E106 | 06/23/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the proxy statement.                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |      1.13588e+06 |                0 | FOR         |                              1.13588e+06 | FOR                         |  |
| Structure Therapeutics Inc.        | 86366E106 | 06/23/2025     | To indicate, on an advisory basis, the preferred frequency of shareholder advisory votes on the compensation of the Company's named executive officers.                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |      1.13588e+06 |                0 | ONE YEAR    |                              1.13588e+06 | FOR                         |  |
| Rhythm Pharmaceuticals, Inc.       | 76243J105 | 06/24/2025     | Approval, on an advisory (non-binding) basis, of the compensation of the named executive officers of the Company.                                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES | 312096           |                0 | FOR         |                         312096           | FOR                         |  |
| Gossamer Bio, Inc.                 | 38341P102 | 06/25/2025     | Approval, on an advisory basis, of the compensation of the Company's named executive officers as disclosed in the proxy statement.                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |      3.26696e+06 |                0 | FOR         |                              3.26696e+06 | FOR                         |  |
| Kymera Therapeutics, Inc.          | 501575104 | 06/25/2025     | To approve, on a non-binding advisory basis, the compensation of our named executive officers; and                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES | 464449           |            20820 | FOR         |                         464449           | FOR                         |  |
| Phreesia, Inc.                     | 71944F106 | 06/25/2025     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement.                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES | 438908           |                0 | FOR         |                         438908           | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** Rock Springs Capital Management LP

**By (Signature):** Nnamdi Etoh

**By (Printed Signature):** Nnamdi Etoh

**By (Title):** Chief Financial Officer

**Date:** 08/22/2025